(Q40505351)

21 September 2017

1 reference

title

Reducing the infectivity of blood components--what we have learned (English)

1 reference

21 September 2017

1 reference

Friedman LI

1

1 reference

21 September 2017

Stromberg RR

series ordinal

2

1 reference

21 September 2017

Wagner SJ

series ordinal

3

1 reference

21 September 2017

publication date

1 January 1995

1 reference

Immunological Investigations

21 September 2017

published in

1 reference

21 September 2017

volume

24

1 reference

21 September 2017

issue

1-2

1 reference

21 September 2017

page(s)

49-71

1 reference

Septic reactions to platelet transfusions. A persistent problem

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Viral inactivation of blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

A novel method for removal of human immunodeficiency virus: filtration with porous polymeric membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Outbreak of hepatitis A among Italian patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

No evidence for protein modifications in fresh frozen plasma after photochemical treatment: an analysis by high-resolution two-dimensional electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Inactivation of viruses in fresh-frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Reduction of HTLV-I-infected cells in blood by leukocyte filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Leukocyte filtration removes infectious particulate debris but not free virus derived from experimentally lysed HIV-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Efficiency of white cell filtration and a freeze-thaw procedure for removal of HIV-infected cells from blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Removal of Yersinia enterocolitica from AS-1 red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Association of herpes simplex virus with platelets of experimentally infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Effect of platelet-associated virus on assays of HIV-1 in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Incidence of Posttransfusion Hepatitis in Previously Frozen Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Hepatitis after the transfusion of frozen red cells and washed red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Transmission of Hepatitis B Virus Infection by Transfusion of Frozen-Deglycerolized Red Blood Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Virucidal levels of ozone induce hemolysis and hemoglobin degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Antiviral activity of merocyanine 540.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Inactivation of viruses in blood with aluminum phthalocyanine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Red cell alterations associated with virucidal methylene blue phototreatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Ionic strength dependence of the binding of methylene blue to chromatin and calf thymus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Effect of prestorage white cell reduction on bacterial growth in platelet concentrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Psoralen/UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

Determination of residual 4'-aminomethyl-4,5',8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139509062762

10.3109/08820139509062762

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference